Addenbrooke's Hospital, University of Cambridge, UK.
Regen Med. 2010 Nov;5(6):857-61. doi: 10.2217/rme.10.82.
Dr Roger A Barker is a University Reader in Clinical Neuroscience and Honorary Consultant in Neurology at the Addenbrooke's Hospital. He trained at Oxford and in London and has been in his current position for 10 years, having completed an MRC Clinician Scientist Fellowship prior to this. His main interests are in the neurodegenerative disorders of the nervous system, in particular Parkinson's disease and Huntington's disease. Dr Barker combines basic research investigating cell therapies to treat these conditions, with clinically based work on defining the natural history and heterogeneity of both diseases. He is a member of the CURE PD Research Advisory Panel and the MRC Stem Cell Liaison Committee. He is a member of the Regenerative Medicine editorial board and co-editor-in-chief of the journals ACNR and the Journal of Neurology.
罗格·A·巴克博士是临床神经科学的大学读者和阿登布鲁克医院的名誉神经病学顾问。他在牛津和伦敦接受培训，在担任目前的职位已经有 10 年了，在此之前他完成了 MRC 临床科学家奖学金。他的主要兴趣在于神经系统的神经退行性疾病，特别是帕金森病和亨廷顿病。巴克博士将治疗这些疾病的基础研究与基于临床的定义这两种疾病的自然史和异质性的工作相结合。他是 CURE PD 研究咨询小组和 MRC 干细胞联络委员会的成员。他是再生医学编辑委员会的成员，也是 ACNR 和神经病学杂志的联合主编。
